This inventor holds 3 USPTO granted patents and 3 published patent applications and 1 EPO patent. Top assignee: Biontech US Inc.. Active years: 2021-2024.
Company Filing History:
Years Active: 2021-2024
Title: Dominik Barthelme: Innovator in HLA-based Technologies
Introduction
Dominik Barthelme is a notable inventor based in Belmont, MA (US). He has made significant contributions to the field of immunology through his innovative work on HLA-based methods and compositions. With a total of 3 patents, Barthelme is recognized for his advancements in the profiling of HLA-peptides.
Latest Patents
Barthelme's latest patents include groundbreaking technologies such as "HLA-based methods and compositions and uses thereof - Systems, compositions, and methods for isolating HLA-peptides from cells." This patent describes a universal platform and methods for profiling the HLA-peptidome, enabling the identification of endogenously presented HLA-peptides from cell lines expressing any possible class I or II construct. Another significant patent is "HLA-based methods and compositions and uses thereof - Compositions and methods for isolating HLA-peptides from cells," which further emphasizes his focus on HLA-peptide profiling.
Career Highlights
Dominik Barthelme is currently employed at BioNTech US Inc., where he continues to develop innovative solutions in the field of biotechnology. His work is pivotal in advancing our understanding of immune responses and therapeutic applications.
Collaborations
Barthelme collaborates with esteemed colleagues such as Michael Steven Rooney and Jennifer Grace Abelin, contributing to a dynamic research environment that fosters innovation.
Conclusion
Dominik Barthelme's contributions to HLA-based technologies highlight his role as a leading inventor in the field. His patents and ongoing work at BioNTech US Inc. continue to push the boundaries of immunological research and applications.